"I'm going to die of something anyway": Women's perceptions of tamoxifen for breast cancer risk reduction

Ethnicity and Disease

Volumn 15, Issue 3, 2005, Pages 365-372

  Paterniti, Debora A ^a,b   Melnikow, Joy ^a   Nuovo, Jim ^a   Henderson, Stuart ^d   DeGregorio, Michael ^b   Kuppermann, Miriam ^c   Nease, Robert ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Breast cancer prevention; Decision making; Ethnicity; Qualitative research

Indexed keywords

HORMONE; TAMOXIFEN;

ADULT; AFRICAN AMERICAN; AGED; ALTERNATIVE MEDICINE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; ETHNOLOGY; FEMALE; HEALTH EDUCATION; HISPANIC; HORMONE SUBSTITUTION; HUMAN; INCOME; INTERVIEW; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PILOT STUDY; QUALITATIVE ANALYSIS; QUESTIONNAIRE; RELIABILITY; RELIGION; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SIDE EFFECT; UNITED STATES;

AGED; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; DECISION MAKING; FEMALE; FOCUS GROUPS; HUMANS; INTERVENTION STUDIES; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; PILOT PROJECTS; TAMOXIFEN;

EID: 24344433427     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1998. CA Cancer J Clin. 1998;48:6-29.
2. Owsborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998;339:1609-1618.
3. Fisher B, Costatino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 1998;90(18):1371-1388.
4. Powles T, Eeles R, Ashley S, et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomized chemoprevention trial. Lancet. 1998; 352:98-101.
5. Veronesi U, Maisonneuve P, Costa A, et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomized trial among hysterectomised women. Lancet. 1998;352:93-97.
6. Gail MH, Brinton LA, Byar LA, et al. Projecting individualized probabilities of developing breast cancer for White females who are being examined annually. J Natl Cancer Inst. 1989;81:1879-1886.
7. DeGregorio M, Maenpaa J, Wiebe V. Tamoxifen for the prevention of breast cancer. No. 12. Important Ad Oncology. 1995:175-185.
8. Non-numerical Unstructured Data-Indexing, Searching, and Theorizing [computer program]. Thousand Oaks, Calif: Scolari, Sage Publications Software; 1994.
9. Rosenstock IM. Why people use health services. Milbank Memorial Fund Q. 1996;44: 94-106.
10. Katz JN. Patient preferences and health disparities. JAMA. 2001;286(12):1506-1509.
11. Wilcox S, Stefanick ML. Knowledge and perceived risk of major diseases in middle-aged and older women. Health Psychol. 1999;18:346-353.
12. Montano DE, Taplin SH. A test of an expanded theory of reasoned action to predict mammography participation. Soc Sci Med. 1991;32(6):733-741.
13. Ajzen I, Fishbein M. Understanding Attitudes and Predicting Social Behaviors. Englewood Cliffs, NJ: Prentice-Hall; 1980.
14. Lauver DR, Kane J, Bodden J, McNeel J, Smith L. Engagement in breast cancer screening behaviors. Oncol Nurs Forum. 1999;26(3):545-554.
15. Pearlman DN, Rakowski W, Ehrich B, Clark MA. Breast cancer screening practices among Black, Hispanic, and White women: reassessing differences. Am J Prev Med. 1996;12(5):327-337.
16. Schneider EC, Cleary PD, Zaslavsky AM, Epstein AM. Racial disparity in influenza vaccination: does managed care narrow the gap between African Americans and Whites? JAMA. 2001; 286(12):1455-1460.
17. Phillips JM, Cohen MZ, Moses G. Breast cancer screening and African-American women: fear, fatalism, and silence. Oncol Nurs Forum. 1999;26(3):561-571.
18. Hubbell FA, Chavez LR, Mishra SI, Valdez RB. Differing beliefs about breast cancer among Latinas and Anglo women. West J Med. 1996;164(5):405-409.
19. Williams DR. Race, socio-economic status and health: the added effects of racism and discrimination. Ann N Y Acad Sci. 1991;896: 173-188.
20. Abrums M. "Jesus will fix it after a while": meanings and health. Soc Sci Med. 2000;50: 89-105.
21. Ferguson JA, Dewar JA. Tamoxifen beyond 5 years - patients' decisions regarding entry to the aTTom trial. Eur J Cancer. 2002;38: 1857-1859.
22. Port ER, Montgomery LL, Heerdt AS, Borgen PI. Patient reluctance toward tamoxifen use for breast cancer primary prevention. Ann Surg Oncol. 2001;8(7):580-585.
23. Hogel LF. Chemoprevention for healthy women: harbinger for things to come? Health. 2001;5(3):311-333.